![David Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Smith
Direktor/Vorstandsmitglied bei
FORTREA HOLDINGS INC.
Vermögen: 524 036 $ am 30.06.2026
Profil
David Ross Smith ist Chief Financial Officer & Executive Vice President bei Charles River Laboratories International, Inc. und im Vorstand von 11 weiteren Unternehmen. In seiner bisherigen Laufbahn war Herr Smith Chief Financial Officer von AstraZeneca Plc, Chief Financial Officer von AstraZeneca AB, Chief Financial Officer bei AstraZeneca BV und Chief Financial Officer von AstraZeneca Kft (alles Tochtergesellschaften von AstraZeneca Plc), CFO & Chief Executive Officer-Galapagos Services bei Galapagos NV und Chief Financial Officer für Cambridge University Hospitals NHS Foundation Trust. Er erhielt einen Bachelor-Abschluss von der University of Leeds.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.06.2026 | 30’117 ( 0.03% ) | 524 036 $ | 30.06.2026 |
Aktive Positionen von David Smith
| Unternehmen | Position | Beginn |
|---|---|---|
| FORTREA HOLDINGS INC. | Direktor/Vorstandsmitglied | 15.06.2023 |
Celsis Ltd.
 Celsis Ltd. Medical DistributorsDistribution Services Develops and supplies diagnostic and monitoring systems | Direktor/Vorstandsmitglied | - |
Charles River Discovery Research Services UK Ltd.
 Charles River Discovery Research Services UK Ltd. Miscellaneous Commercial ServicesCommercial Services Provides drug discovery products and services | Direktor/Vorstandsmitglied | 17.11.2014 |
Celsis Group Ltd.
 Celsis Group Ltd. Chemicals: Major DiversifiedProcess Industries Manufactures chemical products, electronic measuring and testing equipment | Direktor/Vorstandsmitglied | 24.07.2015 |
Charles River Laboratories Holdings Ltd.
 Charles River Laboratories Holdings Ltd. Financial ConglomeratesFinance Provides investment services | Direktor/Vorstandsmitglied | 01.09.2015 |
Charles River UK Ltd.
 Charles River UK Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Direktor/Vorstandsmitglied | 01.09.2015 |
BioFocus DPI (Holdings) Ltd.
 BioFocus DPI (Holdings) Ltd. Financial ConglomeratesFinance Functions as investment holding company | Direktor/Vorstandsmitglied | - |
Charles River Laboratories Edinburgh Ltd.
 Charles River Laboratories Edinburgh Ltd. Pharmaceuticals: MajorHealth Technology Provides scientific research services | Direktor/Vorstandsmitglied | 15.05.2015 |
Charles River Discovery Research Services Finland Oy
 Charles River Discovery Research Services Finland Oy Miscellaneous Commercial ServicesCommercial Services Provides non-clinical central nervous system services to the pharmaceutical and biotechnology industries | Direktor/Vorstandsmitglied | 01.07.2015 |
Ehemalige bekannte Positionen von David Smith
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von David Smith
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
81
Beziehungen ersten Grades
21
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 21 |
|---|---|
Charles River Laboratories Cell Solutions, Inc.
 Charles River Laboratories Cell Solutions, Inc. Chemicals: Major DiversifiedProcess Industries Engages in the provision of bioresearch products and services for customer's research and cell therapy protocols | Process Industries |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Charles River Laboratories International, Inc.
 Charles River Laboratories International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides laboratory testing and research services on a contract basis | Commercial Services |
Charles River Discovery Research Services UK Ltd.
Charles River Discovery Research Services UK Ltd. Miscellaneous Commercial ServicesCommercial Services Provides drug discovery products and services | Commercial Services |
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
Celsis International Ltd.
 Celsis International Ltd. Medical SpecialtiesHealth Technology Develops and supplies medical diagnostic products and laboratory services | Health Technology |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Charles River Laboratories Edinburgh Ltd.
Charles River Laboratories Edinburgh Ltd. Pharmaceuticals: MajorHealth Technology Provides scientific research services | Health Technology |
University of Leeds
 University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Charles River Discovery Research Services Finland Oy
Charles River Discovery Research Services Finland Oy Miscellaneous Commercial ServicesCommercial Services Provides non-clinical central nervous system services to the pharmaceutical and biotechnology industries | Commercial Services |
Nastor Investments Ltd.
 Nastor Investments Ltd. Financial ConglomeratesFinance Acquisition vehicle formed for the purpose of acquiring Celsis International Plc | Finance |
Celsis Ltd.
Celsis Ltd. Medical DistributorsDistribution Services Develops and supplies diagnostic and monitoring systems | Distribution Services |
Charles River Laboratories Holdings Ltd.
Charles River Laboratories Holdings Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
Charles River UK Ltd.
Charles River UK Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Commercial Services |
AstraZeneca BV | |
AstraZeneca Kft. | |
Celsis Group Ltd.
Celsis Group Ltd. Chemicals: Major DiversifiedProcess Industries Manufactures chemical products, electronic measuring and testing equipment | Process Industries |
Cambridge University Hospitals NHS Foundation Trust
 Cambridge University Hospitals NHS Foundation Trust Hospital/Nursing ManagementHealth Services Operates hospitals that provides cardiology, cancer, pediatric and radiology services | Health Services |
Argenta Discovery 2009 Ltd.
 Argenta Discovery 2009 Ltd. Miscellaneous Commercial ServicesCommercial Services Offers contract research drug discovery services | Commercial Services |
BioFocus DPI (Holdings) Ltd.
BioFocus DPI (Holdings) Ltd. Financial ConglomeratesFinance Functions as investment holding company | Finance |
Fortrea Holdings, Inc.
 Fortrea Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a global contract research organization | Commercial Services |
